The angiotensin-converting enzyme gene insertion/deletion polymorphism and effects of quinapril and atorvastatin on haemostatic parameters in patients with coronary artery disease

• References

• 1 Cambien F, Poitier O, Lecerf L. et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
• 2 Samani NJ, Thompson JR, O'Toole L. et al. A metaanalysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996; 94: 708-12.
• 3 Wells PS, Rodger MA, Forgie MA. et al. The ACE D/D genotype is protective against the development of idiopathic deep wein thrombosis and pulmonaty embolism. Thromb Haemost 2003; 90: 829-34.
• 4 Fatini C, Gensini F, Sticchi E. et al. ACE DD genotype: an independent predisposition factor to venous thromboembolism. Eur J Clin Invest 2003; 33: 642-7.
• 5 Jacoby DS, Rader DJ. Renin-angiotensin system and atherothrombotic disease. Arch Intern Med 2003; 163: 1155-64.
• 6 Undas A, Celinska-Löwenhoff M, Kaczor M. et al. New nonlipid effects of statins and their clinical relevance in cardiovascular disease. Thromb Haemost 2004; 91: 1065-77.
• 7 Basso F, Lowe GDO, McMahon AD. et al. Interleukin- 6 – 174G>C polymorphism and risk of coronary heart disease in West of Scotland Coronary Prevention Study (WOSCOPS). Atherioscler Thromb Vasc Biol 2002; 22: 599-604.
• 8 Marian AJ, Safavi F, Ferlic L. et al. Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin. J Am Coll Cardiol 2000; 35: 89-95.
• 9 Rigat B, Hubert C, Corvol P. et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP-1) (dipeptydyl carboxipeptidase 1). Nucl Acids Res 1992; 20: 1433.
• 10 Makris TK, Stavroulakis GA, Dafni UG. et al. ACE/ DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension. Am Heart J 2000; 140: 760-5.
• 11 Folsom AR. Haemostatic risk factors for atherothrombotic disease: an epidemiologic view. Thromb Haemost 2001; 86: 366-73.
• 12 Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002; 252: 283-94.